Why invest in QIAGEN?

World leader in Sample & Assay Technologies
Our automated systems and consumable products empower customers to transform raw biological samples into valuable molecular information. Our products are used in virtually all areas of science, focused on advancing knowledge about the molecular basis of life. More than one billion biological samples are estimated to already have been prepared or analyzed using QIAGEN technologies in laboratories around the world. We market more than 500 core consumable products as well as a number of instrument solutions to customers in 100 countries.

Attractive and growing markets
We sell our products to four major customer classes:

Molecular Diagnostics: healthcare providers supporting many aspects of patient care including prevention, profiling of diseases, personalized healthcare and point of need testing

Applied Testing: government or industry customers using molecular technologies in fields such as forensics, veterinary diagnostics and food safety testing

Academia: researchers exploring the secrets of life such as the mechanisms and pathways of diseases, and in some cases translating that research into drug targets or commercial applications

Track record of growth and innovation
We have grown substantially in recent years with a flexible strategy that includes developing innovative new products, partnering, and acquiring companies or technologies to complement our portfolio and capitalize on diverse growth opportunities, including Personalized Healthcare and expansion into high-growth markets. QIAGEN is pursuing strategic initiatives that aim to:

Grow efficiently and effectively: we pursue sustained growth and improved profitability through operational improvements and a culture that encourages focus, accountability and entrepreneurial decision-making.